Clinical Trials Sponsored by Sai Life Sciences

Total 1580 results

Achieve Life Sciences

Completed

Safety and Efficacy of S-8184 in Treatment of Locally Advanced, Metastatic, or Recurrent TCC of the Urothelium

Urologic Neoplasms
Achieve Life Sciences

Completed

Evaluation of Safety and Efficacy of TOCOSOL(R) Paclitaxel as Initial Treatment for Metastatic Breast Cancer

Breast Cancer

Russian Federation
LG Life Sciences

Completed

Safety and Efficacy Study of LB80380 in the Patients With Lamivudine-Refractory Chronic Hepatitis B

Chronic Hepatitis B

China, Korea, Republic of
CND Life Sciences

Recruiting

The Syn-Sleep Study

REM Sleep Behavior Disorder (iRBD)

United States
Vigonvita Life Sciences

Completed

A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Oral Deuremidevir Hydrobromide for Suspension

Respiratory Syncytial Virus Infections

China
Receptor Life Sciences

Withdrawn

Safety, Tolerability, and Efficacy of RLS103 in Subjects With Acute Anxiety Within Social Anxiety Disorder (SAD)

Social Anxiety Disorder

United States
Achieve Life Sciences

Completed

A Second Study of Cytisinicline for Smoking Cessation in Adult Smokers (ORCA-3)

Smoking Cessation

United States
CND Life Sciences

Completed

Synuclein-One Study

Parkinson Disease | Multiple System Atrophy | Pure Autonomic Failure | Dementia With Lewy Bodies

United States
Achieve Life Sciences

Completed

Study to Evaluate the Effect of Renal Impairment and Dialysis Treatment on the Pharmacokinetics of a Single 3 mg Cytisinicline Dose

Renal Impairment

Spain, Portugal
Vigonvita Life Sciences

Completed

Drug-Drug Interaction (DDI) Study for TPN171H

Erectile Dysfunction

China
Vigonvita Life Sciences

Completed

Pharmacodynamic Study of TPN171H Tablets in Patients With Mild to Moderate Erectile Dysfunction

Erectile Dysfunction

China
Vigonvita Life Sciences

Completed

Effect of TPN171H on Spermatogenesis

Erectile Dysfunction

China
Vigonvita Life Sciences

Completed

Efficacy and Safety of JT001 (VV116) Compared With Paxlovid

COVID-19

China
Vigonvita Life Sciences

Completed

A Study of the Hemodynamic Interactions of TPN171H Tablets & Alcohol in Healthy Male Subjects

Erectile Dysfunction | Alcohol | Phosphodiesterase Inhibitor

China
Vigonvita Life Sciences

Completed

Food Effect on Pharmacokinetic Profiles of VV116 Administered Orally to Chinese Healthy Volunteers

Healthy Subjects

China
Achieve Life Sciences

Completed

Trial of Cytisine in Adult Smokers

Smoking Cessation

United States
Achieve Life Sciences

Completed

A Study in Healthy Smokers to Investigate the Effect of Food on the Bioavailability of Cytisine in a New Formulation

Smoking Cessation

United Kingdom
LG Life Sciences

Completed

Clinical Study to Evaluate the Correction of Facial Wrinkles and Folds and Safety of YVOIRE Volume Versus Perlane in Nasolabial Fold Injection

Temporary Correction of Wrinkles
LG Life Sciences

Completed

Extension Clinical Study to Evaluate the Long-term Efficacy and Safety of Repeat Treatment of YVOIRE Contour Injected Into the Anteromedial Malar Region in Subjects Who Have Completed the LG-HACL014 Study

Normal, Healthy Adults With Moderate, Severe, or Very Severe Volume Loss of Anteromedial Malar Region Who Have Completed the LG-HACL014 Study

Korea, Republic of
LG Life Sciences

Completed

A Phase I Clinical Trial of a 13-valent Pneumococcal Conjugate Vaccine and 14-valent Pneumococcal Conjugate Vaccine in Adults

Pneumococcal Infections

Korea, Republic of
Transparency Life Sciences

Unknown

Decentralized Dietary UC Pilot Trial

Colitis, Ulcerative

United States
LG Life Sciences

Unknown

Phase III Trial to Evaluate the Efficacy and Safety of Gemigliptin 50mg qd Added to Ongoing Glimepiride as Fix-dose Combination in Patients With Type 2 Diabetes

Type 2 Diabetes Mellitus

Korea, Republic of
LG Life Sciences

Completed

Safety and Pharmacokinetics Between Fixed-dose Combination VR 160/20 mg and Co-administration of Diovan® (Valsartan) Film-coated Tablet 160 mg and Crestor® (Rosuvastatin) 20 mg

Hypertension | Hyperlipidemia

Korea, Republic of
LG Life Sciences

Completed

Phase 4 Trial to Evaluate the Efficacy and Safety of Sancuso Patch in Chemotherapy-induced Nausea and Vomiting Associated With the Administration of Highly Emetogenic Chemotherapy (HEC)

Chemotherapy-induced Acute or Delayed Nausea and Vomiting (CINV)

Korea, Republic of
LG Life Sciences

Completed

Phase I Trial for Pharmacokinetic Characteristics of Factive 200mg Intravenous Formulation (Gemifloxacin 200mg) With Factive 320mg Tablet Formulation (Gemifloxacin 320mg)

Infectious Diseases

Korea, Republic of
LG Life Sciences

Completed

Safety, Tolerability and Pharmacokinetic/Pharmacodynamic Characteristics of LC350189

Hyperuricemia | Gout

Korea, Republic of
LG Life Sciences

Completed

Efficacy and Safety of LBSA0103 Versus Hyruan Plus Injection in Patients With Knee Osteoarthritis

Osteoarthritis of the Knee

Korea, Republic of
LG Life Sciences

Completed

Study in Healthy Male Subjects Designed to Assess the Mass Balance Recovery, Metabolite Profile and Metabolite Identification of [14C] LC15-0444

Healthy

Korea, Republic of
LG Life Sciences

Completed

Pharmacokinetic/Pharmacodynamic Drug-drug Interaction of LC15-0444 and Metformin After Oral Administration in Healthy Male Subjects

Healthy

Korea, Republic of
LG Life Sciences

Completed

Efficacy and Safety of Lercanidipine and Valsartan in Patients With Essential Hypertension

Essential Hypertension

Korea, Republic of
LG Life Sciences

Completed

Immunogenicity and Safety Study of LBVH0101 in Healthy Infants at Two, Four and Six Months of Age

Infectious Disease by Haemophilus Influenzae Type b

Korea, Republic of
Kolon Life Science

Completed

Efficacy and Safety Study of TissueGene-C Mixed With Fibrin-glue for the Patients With Degenerative Arthritis

Degenerative Arthritis

Korea, Republic of
Kolon Life Science

Completed

Efficacy and Safety Study of TissueGene-C to Degenerative Arthritis

Degenerative Arthritis

Korea, Republic of
Kolon Life Science

Enrolling by invitation

A Long-term, 3-Year, Follow-up Study for Patients Completing the KS-GIG-001-01 Study

Lumbosacral Radiculopathy

United States
Kolon Life Science

Unknown

The Efficacy and Safety of Invossa K Injection in Patients Diagnosed With Knee Osteoarthritis

Osteoarthritis

Korea, Republic of
Kolon Life Science

Completed

Efficacy and Safety Study of TissueGene-C to Degenerative Arthritis

Degenerative Arthritis

Korea, Republic of
Kolon Life Science

Completed

Efficacy and Safety Study of TissueGene-C to Degenerative Arthritis

Degenerative Arthritis

Korea, Republic of
Kolon Life Science

Active, not recruiting

Single Ascending Doses Study of KLS-2031 in Subjects With Neuropathic Pain From Lumbosacral Radiculopathy

Lumbosacral Radiculopathy

United States
Kolon Life Science

Active, not recruiting

A Post Marketing Surveillance Study of INVOSSA K Inj.

Osteoarthritis

Korea, Republic of
Kolon Life Science

Completed

Safety and Biological Efficacy Study of TisssueGene-C to Degenerative Arthritis

Degenerative Arthritis

Korea, Republic of
Power Life Sciences Inc.

Not yet recruiting

Understanding Participation Habits Among Plaque Psoriasis Patients

Plaque Psoriasis

United States
Power Life Sciences Inc.

Not yet recruiting

Understanding Patient Engagement Trends in TBI Clinical Research

TBI

United States
Power Life Sciences Inc.

Not yet recruiting

An Observational Exploration of Clinical Trials Targeting Traumatic Brain Injury

Traumatic Brain Injury

United States
Power Life Sciences Inc.

Not yet recruiting

Understanding of Participation Trends Within Generalized Anxiety Disorder Patients Involved in Clinical Trials

Generalized Anxiety Disorder

United States
Power Life Sciences Inc.

Not yet recruiting

A Journey Into Participation Patterns Among Patients With Hidradenitis Suppurativa

Hidradenitis Suppurativa

United States
ReAlta Life Sciences, Inc.

Recruiting

Safety, PK and PD Relationships of RLS-0071 in Patients With Acute Exacerbation of Chronic Obstructive Pulmonary Disease

Acute Exacerbation of Chronic Obstructive Pulmonary Disease

United States
Power Life Sciences Inc.

Not yet recruiting

Understanding Patient Engagement Trends in Anxiety Disorder Clinical Research

Anxiety Disorder

United States
Power Life Sciences Inc.

Not yet recruiting

Studying Patterns in Patient Engagement Among Treatment Resistant Depression Patients

Treatment Resistant Depression

United States
Power Life Sciences Inc.

Not yet recruiting

Revealing Engagement Dynamics Among Diabetic Kidney Disease Patients

Diabetic Kidney Disease

United States
Power Life Sciences Inc.

Not yet recruiting

Delving Into Participation Trends in Renal Cell Carcinoma Studies

Renal Cell Carcinoma

United States

3

Subscribe